Total Funding
6
Total FundingSeries B raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
TCD Pharma is a biotechnology company engaged in the discovery, development and commercialization of oncology drugs.
Pablo Cabello Albendea: President & Chairman of the Board- Ran Vigdor: Chief Executive Officer
About the Company
Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the future of Oncology by developing innovative therapies that address unmet medical needs.
Established in 2005 and with one product, TCD-717, already in clinical trials the Company is positioning itself as Spain’s Partner of Choice for Oncology drug
discovery and development opportunities.
TCD’s strong management team, its strategy of building its pipeline through in-licensing and partnerships and by leveraging resources through collaborations and outsourcing via premier Contract Research Organizations, allows TCD to be in the forefront of Oncology drug development while significantly lowering risks and costs.
